Nantahala Capital Management’s Medifast MED Stock Holding History

Nantahala Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$3.11M	–	133
2023 Q1	$3.11M	Hold	30,000	–	–	0.24%	65
2022 Q4	$3.46M	Buy	+30,000	New	+$3.49M	0.22%	62
2020 Q3	–	Sell	-272,957	Closed	-$37.9M	–	120
2020 Q2	$37.9M	Hold	272,957	–	–	1.14%	21
2020 Q1	$17.1M	Buy	272,957 +142,957	+110%	+$13M	0.64%	31
2019 Q4	$14.2M	Buy	130,000 +8,593	+7%	+$832K	0.44%	43
2019 Q3	$12.6M	Buy	+121,407	New	+$13M	0.47%	46

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nantahala Capital Management's MED Position: Q2 2023 in Review

Nantahala Capital Management sold out of Medifast (MED) in Q2 2023, closing a stake of 30,000 shares — an estimated $3.11M sold.

Nantahala Capital Management first reported a position in MED in Q3 2019 and held it in 6 quarters. The position peaked at $37.9M in Q2 2020. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Nantahala Capital Management reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Nantahala Capital Management sold 30,000 Medifast shares in Q2 2023, an estimated $3.11M.
Nantahala Capital Management first reported a position in Medifast in Q3 2019 and held it in 6 quarters.
Nantahala Capital Management's Medifast position peaked at $37.9M in Q2 2020.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Nantahala Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.